Table 2.
Metformin | Placebo | P-value | |
---|---|---|---|
N | 45 | 39 | 0.55 |
Age (years) | 10.1 ± 0.25 | 10.3 ± 0.22 | 0.66 |
Female sex (%) | 35.9 | 44.4 | 0.43 |
Race/ethnicity (%) | 0.76 | ||
Non-Hispanic White | 46.7 | 51.3 | - |
Non-Hispanic Black | 37.7 | 38.5 | - |
Hispanic White | 6.7 | 7.7 | - |
Other | 8.9 | 2.6 | - |
Weight (kg) | 76.7 ± 3.6 | 80.0 ± 3.5 | 0.51 |
BMI (kg/m2) | 34.8 ± 1.0 | 34.7 ± 1.1 | 0.94 |
BMI SD score for age and sex | 2.9 ± 0.03 | 2.9 ± 0.04 | 0.45 |
Total fat mass by DEXA (kg) | 38.9 ± 2.5 | 38.7 ± 2.4 | 0.85 |
Total lean mass by DEXA (kg) | 37.4 ± 1.3 | 40.7 ± 1.4 | 0.08 |
REE (kcal/24h) | 1696.4 ± 51.2 | 1700.8 ± 285.1 | 0.95 |
Hemoglobin A1C (%) | 5.5 ± 0.09 | 5.4 ± 0.07 | 0.16 |
Fasting serum insulin (pmol/L) | 144.2 ± 10.1 | 138.5 ± 11.5 | 0.51 |
Fasting plasma glucose (mmol/L) | 5.12 ± 0.07 | 5.06 ± 0.07 | 0.54 |
Fasting serum leptin (pmol/L) | 1820 ± 168 | 1850 ± 190 | 0.80 |
Food array I energy intake (kcal) | 1372.3 ± 103.8 | 1350.9 ± 87.8 | 0.95 |
Pre-Food array I ratings | |||
Hunger | 68.5 ± 3.7 | 68.3 ± 3.5 | 0.56 |
Fullness | 21.9 ± 4.0 | 17.9 ± 3.3 | 0.96 |
Desire to eat | 65.3 ± 2.7 | 58.9 ± 2.4 | 0.11 |
Post-Food array I ratings | |||
Hunger | 5.8 ± 1.7 | 3.9 ± 0.7 | 0.25 |
Fullness | 78.1 ± 3.9 | 80.5 ± 4.3 | 0.30 |
Desire to eat | 11.7 ± 2.7 | 9.3 ± 3.1 | 0.30 |
Ratings before pre-meal load | |||
Hunger | 54.3 ± 4.3 | 57.3 ± 4.3 | 0.63 |
Fullness | 12.5 ± 2.5 | 13.8 ± 2.7 | 0.73 |
Desire to eat | 58.6 ± 3.2 | 55.3 ± 3.5 | 0.49 |
Pre-meal load energy intake (kcal) | 872.0 ± 57.9 | 853.4 ± 34.1 | 0.79 |
Ratings after pre-meal load | |||
Hunger | 67.7 ± 4.1 | 68.7 ± 3.8 | 0.77 |
Fullness | 11.4 ± 2.3 | 12.8 ± 2.7 | 0.61 |
Desire to eat | 69.3 ± 3.1 | 59.9 ± 3.3 | 0.10 |
Food array II energy intake (kcal) | 1331.5 ± 101.5 | 1262.5 ± 81.2 | 0.63 |
Post-Food array II ratings: | |||
Hunger | 6.6 ± 2.3 | 3.6 ± 0.6 | 0.43 |
Fullness | 77.1 ± 4.1 | 73.2 ± 5.4 | 0.97 |
Desire to eat | 9.3 ± 2.7 | 8.6 ± 3.2 | 0.69 |
Data are presented as means ± SEM unless otherwise indicated. At baseline, there were no significant differences between treatment groups. BMI: body mass index; REE: resting energy expenditure